need help, page-4

Just put out an announcement............. Gatesy

Document date: Wed 11 Jun 2003 Published: Wed 11 Jun 2003 09:31:26
Document No: 238740 Document part: A Market Flag: Y Classification: Other
AFT CORPORATION LIMITED 2003-06-11 ASX-SIGNAL-G
HOMEX - Perth
+++++++++++++++++++++++++
Microgenix is pleased to announce that it has signed further sales
contracts in the past few days.

RUSSIA

Five units are destined for the EMC (European Medical Centre) in
Moscow These clinics are at the forefront of Russian medical services
and are generally accepted as the leading group in its field. They
employ only the highest skilled and most experienced surgeons and
physicians and are supported by the very latest hi-tech equipment. To
maintain their position the EMC are installing five Microgenix air
purification units for initial evaluation.

UK

A Letter of Intent has been received for an initial order for 22
Microgenix air purification units for a hospital in the north of
England. Both the hospital in Southern Ireland and the hospital in
the north of England have requested that their identities remain
confidential. Eight units have been ordered for a private mansion
house in London.

IRELAND

A duct mounted system has been purchased by a leading university
hospital in Southern Ireland. This initial order has come about
following legislation which prevents hospitals from venting exhaust
gases from isolation wards into the atmosphere untreated. Most
significantly this hospital is a test hospital for a chain which
controls over 200 hospitals.

GREECE AND SLOVENIA

Negotiations are proceeding for hospital and major event trials.

NEW LEGISLATION FORCES HOSPITALS TO TREAT EXHAUST GASES FROM
ISOLATION WARDS

Mr Lindsay Sanford, the Chairman of AFT CORPORATION LTD said "The
legislation that has just been released requiring hospitals to
install air filtering systems to treat exhaust gases from all
isolation wards opens up a huge new market for Microgenix. It is now
crunch time for medical establishments to face the reality of having
to look closely at the air purification market for answers to their
problems of the everyday risks of cross contamination and contagious
diseases spreading uncontained. This change in legislation is a
potential windfall for Microgenix."

CLARIFICATION OF ERROR - SURROGATES USED IN ALL TESTING

It has been pointed out to the Directors that we inadvertently made
an error in material released to the market on 27 May 2003 concerning
testing carried out at CAMR, Porton Down for Microgenix Technologies
Ltd. This statement is intended to acknowledge, clarify and correct
the error made in the previous statement.

In that report it was not made clear that surrogates were used for
all Smallpox and Tuberculosis tests carried out at CAMR at Porton
Downs for Microgenix Technologies Ltd.

The surrogates used are very closely related to Smallpox and
Tuberculosis micro organisms. They are just as difficult to eradicate
but, as is normal practice, a surrogate is used as it is less toxic
and hence much safer in testing.

CAMR are part of the UK Department of Health and are completely
independent of Microgenix Technologies Limited.

CAMR are not available for comment on any testing as all tests are
carried out under Confidentiality Agreements.

Any further questions should be referred to directly to
[email protected].

Ph: 02 9988 0833
Fx: 02 9988 0855